Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | L01EG03 |
UNII: | 48Z35KB15K |
InChI Key | BUROJSBIWGDYCN-GAUTUEMISA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C53H84NO14P |
Molecular Weight | 990.22 |
AlogP | 7.74 |
Hydrogen Bond Acceptor | 14.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 8.0 |
Polar Surface Area | 201.5 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 69.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Serine/threonine-protein kinase mTOR inhibitor | PubMed |
Primary Target | |
---|---|
mechanistic target of rapamycin kinase |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Neoplasms | 3 | D009369 | ClinicalTrials |
Sarcoma | 3 | D012509 | ClinicalTrials |
Osteosarcoma | 3 | D012516 | ClinicalTrials |
Sarcoma | 3 | D012509 | ClinicalTrials |
Osteosarcoma | 3 | D012516 | ClinicalTrials |
Leiomyosarcoma | 2 | D007890 | ClinicalTrials |
Leukemia | 2 | D007938 | ClinicalTrials |
Liposarcoma | 2 | D008080 | ClinicalTrials |
Lymphoma | 2 | D008223 | ClinicalTrials |
Primary Myelofibrosis | 2 | D055728 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Myelodysplastic Syndromes | 2 | D009190 | ClinicalTrials |
Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Gliosarcoma | 1 | D018316 | ClinicalTrials |
Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 572924-54-0 |
ChEBI | 79700 |
ChEMBL | CHEMBL2103839 |
DrugBank | DB06233 |
DrugCentral | 4778 |
FDA SRS | 48Z35KB15K |
Guide to Pharmacology | 7884 |
KEGG | C15183 |
PubChem | 11520894 |
SureChEMBL | SCHEMBL7719298 |
ZINC | ZINC000169677038 |